The Next Generation of Biologics: Use of Real-World Evidence

November 4, 2022 / Washington, DC

There is no registration fee for this course.

This course is at it's capacity. To be included on the waitlist, please call Customer Service at 847-823-7186.

During this symposium, experts in science, medicine, and industry, along with regulatory agencies will convene to examine what we currently know about Real-World Evidence (RWE) as it pertains to musculoskeletal medicine.

This multi-stakeholder discussion will serve two purposes:

  1. Serve as a springboard to begin discussions on how we need to collect RWE in the future to deliver efficacious, safe Orthobiologic therapy to our patients
  2. Establish essential elements for the construction of future biologic registry and biorepository systems.

Attendees will also have the opportunity to interact with the faculty during facilitated Q&A sessions.

Course Directors

Jason Dragoo, MD, PhD, FAAOS

Shane A. Shapiro, MD, FAAOS